SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Balchem Corp – ‘8-K’ for 6/18/20

On:  Tuesday, 6/23/20, at 10:45am ET   ·   For:  6/18/20   ·   Accession #:  1140361-20-14524   ·   File #:  1-13648

Previous ‘8-K’:  ‘8-K’ on / for 5/1/20   ·   Next:  ‘8-K’ on / for 7/31/20   ·   Latest:  ‘8-K’ on 3/29/24 for 3/25/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/23/20  Balchem Corp                      8-K:5,9     6/18/20   11:267K                                   Broadridge Fin’l So… Inc

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     30K 
 2: EX-3.2      Articles of Incorporation/Organization or Bylaws    HTML     83K 
11: R1          Document and Entity Information                     HTML     49K 
 6: XML         IDEA XML File -- Filing Summary                      XML     11K 
 7: XML         XBRL Instance -- form8k_htm                          XML     15K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- bcpc-20200618_lab                     XML     65K 
 5: EX-101.PRE  XBRL Presentations -- bcpc-20200618_pre              XML     47K 
 3: EX-101.SCH  XBRL Schema -- bcpc-20200618                         XSD     15K 
 8: JSON        XBRL Instance as JSON Data -- MetaLinks               14±    20K 
 9: ZIP         XBRL Zipped Folder -- 0001140361-20-014524-xbrl      Zip     29K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C: 
 i false i 12-31 i BALCHEM CORP i MD i false i 000000932600000093262020-06-182020-06-18

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM  i 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (date of earliest event reported):   i June 18, 2020

Balchem Corporation
(Exact name of registrant as specified in its charter)

Maryland
 i 001-13648
 i 13-2578432
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

 i 52 Sunrise Park Road,  i New Hampton,  i NY  i 10958
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: ( i 845)  i 326-5600

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 i 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 i 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 i 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 i 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on
which registered
 
 i Common Stock, par value $.06-2/3 per share.
 
 i BCPC
 
 i NASDAQ Global Market

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.03 - Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
 
On June 18, 2020, the Board the Corporation amended and restated its Bylaws. The amendments include the following: (i) a change to make the date of the annual shareholders’ meeting more general rather than specifying a particular month; (ii) addition of the offices of Chief Executive Officer and Chief Financial Officer; (iii) certain provisions for the giving of electronic notice; (iv) an advance notice provision for shareholder nominations and proposals; (v) clarifications with respect to the voting of shares by certain shareholders (corporations, limited liability companies, joint ventures, trusts or other entities); (vi) clarification that a directors meeting may adjourned if less than a majority of directors is present; (vii) clarification with respect to the number of directors required to adopt resolutions, (viii) a provision requiring that the removal of director may only be accomplished by special shareholders’ or directors’ meeting convened for such purpose; (ix) the addition of a provision for telephonic meetings; (x) specification with respect to those individuals who may chair shareholders and directors’ meetings; (xi) a reliance provision – specifying that directors may rely on certain information provided to them in the performance of their duties; (xii) the addition of a ratification provision;  (xiii) the addition of a provision for emergency meetings; (xiv) clarification with respect to the use of the corporate seal; (xv) the addition of an advancement of expenses provision to the directors’ and officers’ indemnification; (xvi) the addition of provision requiring a supermajority vote for the repeal of the advance notice provision; and (xvii) an exclusive forum provision.
 
Item 5.07 - Submission of Matters to a Vote of Security Holders
 
The Company held its Annual Meeting of Stockholders on June 18, 2020 (“Annual Meeting”).  Set forth below is information regarding the results of the matters voted on by stockholders at the Annual Meeting:
 
(i)         Election of three Class 3 Directors to serve to serve until the Company’s annual meeting of stockholders in 2023 and thereafter until their respective successors are elected and qualified:
 
Director Nominee
Votes For
Votes Withheld
Broker Non-Votes
David Fischer
26,881,645
124,209
2,607,552
Perry Premdas
24,508,975
2,496,879
2,607,552
Dr. John Televantos
24,287,257
2,718,597
2,607,552

(ii)        Ratification of the appointment of RSM LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2020:  29,237,489 shares in favor; 363,683 shares against; 12,234 shares abstaining.
 
(iii)      Advisory vote to approve the Company’s executive compensation: 26,165,157 shares in favor; 793,661 shares against; 47,036 shares abstaining; and 2,607,552 broker non-votes.
 
Item 9.01 Financial Statements and Exhibits
 
(c)
Exhibits

Amended and Restated By-laws – Effective June 18, 2020.


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
BALCHEM CORPORATION
   
 
By:/s/ Mark Stach
 
Mark Stach, General Counsel and Secretary
   
 




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
12/31/20
Filed on:6/23/20
For Period end:6/18/20DEF 14A
 List all Filings 
Top
Filing Submission 0001140361-20-014524   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 25, 7:00:27.1pm ET